Activity of Cyprofloxacine from implant with cross link agent genipin in composites to Staphilococcus aureus ATCC25923 dan Escherichia coli ATCC 25922

Esti Hendradi and Dewi Melani Hariyadi and Muhammad Faris Adrianto (2016) Activity of Cyprofloxacine from implant with cross link agent genipin in composites to Staphilococcus aureus ATCC25923 dan Escherichia coli ATCC 25922. In: Proceeding The 4th Current Drug Development International Conference (CDD 2016). Faculty of Pharmaceutical Sciences, Princes of Songkla University, Songkhla, pp. 188-189. ISBN 978-616-271-303-3

[img] Text (FULLTEXT)
Bukti C-50_opt.pdf

Download (2MB)
[img] Text (SIMILARITY)
Result Bukti C-50.pdf

Download (946kB)
[img] Text (PEER REVIEW)
C-50 Reviewer.pdf

Download (1MB)

Abstract

The Research on effectiveness of cyprofloxacin against Staphylococcus aureus ATCC25923 and Escherichia coli NICC 25922bacteria was done. Composite mixture used was Bovine Hydroxyapatite-Chitosan which cross link with genipin as the carrier Ciprofloxacin. The ratio between Ciprofloxacin: BHA: Chitosan: l0:30:60. As Cross linker was genipin 0.7o ,the concentration of Ciprofloxacin as active ingredient was 10%. The results showed that the implant can release preparation Cyprofloxacin by sustained released system in vitro and to inhibit bacterial growth Staphilococcus aureus ATCC25923 and also Escherichia coli ATCC 25922.

Item Type: Book Section
Subjects: R Medicine
R Medicine > RS Pharmacy and materia medica
R Medicine > RS Pharmacy and materia medica > RS1-441 Pharmacy and materia medica
R Medicine > RS Pharmacy and materia medica > RS200-201 Pharmaceutical dosage forms
Divisions: 05. Fakultas Farmasi
Creators:
CreatorsNIM/NIDN
Esti HendradiNIDN0014115703
Dewi Melani HariyadiNIDN0026027801
Muhammad Faris AdriantoNIDN0002038501
Depositing User: Mr M. Fuad Sofyan
Date Deposited: 04 Jan 2019 08:13
Last Modified: 03 Jan 2020 01:53
URI: http://repository.unair.ac.id/id/eprint/77627
Sosial Share:

Actions (login required)

View Item View Item